Si prevede che il mercato dell'analisi a cella singola crescerà da 3,18 miliardi di dollari nel 2021 a 8,20 miliardi di dollari entro il 2028; si prevede che crescerà a un CAGR del 14,5% dal 2022 al 2028.
L'analisi di singole cellule consente un'analisi approfondita della differenziazione delle cellule staminali, del cancro e delle funzioni fisiologiche negli embrioni e adulti. Tecnologie avanzate come le tecnologie di sequenziamento di singole cellule, ibridazione in situ, rilevamento basato sulla fluorescenza e spettroscopia di massa possono essere utilizzate per studiare le malattie e lo sviluppo di farmaci, per cui si prevede che il mercato dell'analisi di singole cellule crescerà in modo esponenziale.
DINAMICHE DEL MERCATO
La crescita del mercato dell'analisi unicellulare è principalmente attribuita all'aumento della ricerca e sviluppo nei settori farmaceutico e biotecnologico, all'aumento del numero di casi di cancro, alla tecnologia progressi e la crescente domanda di medicina personalizzata. Inoltre, si prevede che i rapidi progressi nella ricerca sul cancro e la collaborazione strategica tra i principali attori alimenteranno il mercato dell’analisi unicellulare durante il periodo di previsione. Tuttavia, i costi elevati e la carenza di professionisti qualificati sono fattori che ostacolano la crescita del mercato.
AMBITO DI MERCATO
L'"Analisi globale di una singola cella" Analisi di mercato fino al 2028” Il rapporto mira a fornire una panoramica del mercato con una segmentazione dettagliata in base a prodotto, tipo di cellula, tecnica, applicazione e utente finale. Il rapporto fornisce statistiche chiave di mercato basate sulle prestazioni dei principali attori. Offre inoltre tendenze e opportunità chiave nel mercato.
Approfondimenti strategici
SEGMENTAZIONE DEL MERCATO
Il mercato globale dell’analisi unicellulare è segmentato in prodotto, tipo di cellula, tecnica, applicazione e utente finale. In base al prodotto, il mercato è suddiviso in beni di consumo e strumenti. Per tipo di cellula, il mercato è segmentato in cellule umane, cellule animali e cellule microbiche. In termini di tecnica, il mercato è classificato in citometria a flusso, sequenziamento di nuova generazione, reazione a catena della polimerasi, microscopia, spettrometria di massa e altre tecniche. Dal punto di riferimento dell'applicazione, il mercato è biforcato in applicazioni di ricerca e applicazioni mediche. Il segmento degli utenti finali è ulteriormente segmentato in laboratori accademici e di ricerca, aziende biotecnologiche e farmaceutiche, ospedali e laboratori diagnostici, banche cellulari e centri di fecondazione in vitro.
QUADRO REGIONALE
Il mercato globale dell'analisi a cella singola è segmentato in cinque regioni principali: Nord America, Europa, Asia Pacifico, Medio Oriente e Stati Uniti. Africa e Sud & America Centrale. Il rapporto copre l'analisi e le previsioni di 18 paesi insieme alle tendenze e alle opportunità prevalenti nella regione.
Dal punto di vista regionale, il Nord America ha dominato il mercato dell'analisi a cella singola con una quota di mercato di circa il 42% nel 2021. la crescita del mercato nella regione è principalmente attribuita all’aumento della spesa per ricerca e sviluppo e ai finanziamenti governativi, alla crescita dell’industria farmaceutica e delle scienze della vita e alle iniziative strategiche di attori importanti insieme all’esistenza di importanti attori nella regione. Ad esempio, nel gennaio 2022, Amgen ha stretto una partnership con Generate Biomedicines per scoprire e creare terapie proteiche per cinque target in varie aree terapeutiche e molteplici funzionalità con investimenti di miliardi di dollari. Inoltre, l’elevata incidenza di malattie croniche come i tumori nella regione sta guidando la crescita del mercato. La figura seguente mostra il trend di crescita dei ricavi nel mercato globale dell'analisi a cella singola:
Fonte: The Insight Partners Analysis< /em>
Il rapporto analizza fattori quali fattori trainanti, restrizioni, opportunità e tendenze future, che influenzano il mercato dell’analisi unicellulare. Fornisce inoltre un'analisi esaustiva delle cinque forze di Porter del mercato dell'analisi a cellula singola.
IMPATTO DELLA PANDEMIA DA COVID-19
L'analisi a cellula singola aiuta nell'interpretazione della risposta immunitaria periferica all'infezione da COVID-19 e contribuisce a nuovi approcci per la ricerca sui meccanismi della malattia e sulle opzioni terapeutiche, con conseguente maggiore adozione di prodotti di analisi unicellulari per la ricerca sul COVID-19. Pertanto, si prevede che l’aumento della domanda di prodotti e le attività di ricerca in corso creeranno opportunità di crescita del mercato. Sebbene varie decisioni governative dovute alle condizioni economiche pandemiche abbiano limitato la produzione complessiva, i prodotti di analisi unicellulare hanno assistito alla crescente domanda di sviluppo e produzione di vaccini in tutto il mondo. Pertanto, il mercato dell'analisi a cella singola è stato influenzato positivamente durante la pandemia di COVID-19.
ATTORI DI MERCATO
Il rapporto copre gli sviluppi chiave nell'analisi a cella singola mercato di analisi. Diverse aziende si stanno concentrando su strategie di crescita organica, come lanci di prodotti, approvazioni di prodotti, brevetti ed eventi. Strategie di crescita inorganica come acquisizioni, partnership e collaborazioni hanno incoraggiato l’espansione del business e della base di clienti degli attori del mercato. Si prevede che gli operatori di mercato che operano nel mercato dell'analisi unicellulare sperimenteranno opportunità di crescita redditizie nei prossimi anni con la crescente domanda di prodotti di analisi unicellulare.
Il rapporto include anche i profili dei principali società di mercato dell’analisi cellulare, insieme alle loro analisi SWOT e strategie di mercato. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie negli ultimi tre anni e sviluppi chiave negli ultimi cinque anni. Di seguito è riportato l'elenco di alcune società impegnate nel mercato dell'analisi di celle singole:
- Tecnologie Agilent
- Beckman Coulter Inc.
- Becton Dickinson & Azienda (BD)
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- GE Healthcare
- Illumina, Inc.
- Merck KGaA
- Qiagen NV
- Thermo Fisher Scientific, Inc.
Il team di ricerca e analisi dedicato del partner Insight è composto da professionisti esperti con competenze statistiche avanzate e offre varie opzioni di personalizzazione nello studio esistente.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Agilent Technologies
2. Beckman Coulter Inc.
3. Becton Dickinson & Company (BD)
4. Bio-Rad Laboratories, Inc.
5. Fluidigm Corporation
6. GE Healthcare
7. Illumina, Inc.
8. Merck KGaA
9. Qiagen N.V.
10. Thermo Fisher Scientific, Inc.
11. Danaher Corporation
12. Merck Millipore
13. 10x Genomics
14. Promega Corporation
15. NanoString Technologies
16. Tecan Group
17. Sartorius AG
18. Luminex Corporation
19. Takara Bio
20. Fluxion Biosciences
21. Menarini Silicon Biosystems
22. LumaCyte
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)